These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2884701)

  • 21. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current orientation in medical management of ulcerative colitis].
    Grassi M; Raffa S; Damiani VC; Fontana M
    Clin Ter; 1995 May; 146(5):327-41. PubMed ID: 7796565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment of ulcerative colitis].
    Turunen U; Järvinen HJ
    Duodecim; 1993; 109(2):145-51. PubMed ID: 7912179
    [No Abstract]   [Full Text] [Related]  

  • 24. [Exanthema in 2 patients with ulcerative colitis treated with Pentasa].
    Grøn I; Winther A
    Ugeskr Laeger; 1988 Jan; 150(1):32. PubMed ID: 2967564
    [No Abstract]   [Full Text] [Related]  

  • 25. Five-aminosalicylic acid enemas in treatment of ulcerative colitis.
    Fedotin MS
    Mo Med; 1985 Jun; 82(6):301-3. PubMed ID: 4010664
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E; Bock H
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects with oral 5-aminosalicyclic acid.
    Fardy JM; Lloyd DA; Reynolds RP
    J Clin Gastroenterol; 1988 Dec; 10(6):635-7. PubMed ID: 2906645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
    Tolia V
    Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
    Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
    Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of free oxygen radicals for pathogenesis of chronic inflammatory disease].
    Nielsen OH; Ahnfelt-Rønne I
    Ugeskr Laeger; 1992 Sep; 154(38):2544-6. PubMed ID: 1357806
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment and recurrence prevention ulcerative colitis].
    Schölmerich J
    Internist (Berl); 1995 Dec; 36(12):1124-32. PubMed ID: 8567217
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
    Loizeau E
    Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
    [No Abstract]   [Full Text] [Related]  

  • 33. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
    Hanauer S; Schwartz J; Robinson M; Roufail W; Arora S; Cello J; Safdi M
    Am J Gastroenterol; 1993 Aug; 88(8):1188-97. PubMed ID: 8338086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Conservative therapy of ulcerative colitis--long-term experience].
    Kölbel C; Goebell H
    Internist (Berl); 1991 Sep; 32(9):530-9. PubMed ID: 1683664
    [No Abstract]   [Full Text] [Related]  

  • 35. Pentasa in lieu of sulfasalazine.
    Mulder CJ; Tytgat GN; Dekker W; Terpstra IJ
    Ann Intern Med; 1988 Jun; 108(6):911-2. PubMed ID: 2897181
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experience in the use of salazopyrine EN in patients with spondylarthritis ankylopoietica and rheumatoid arthritis].
    Somhegyi A; Gömör B
    Orv Hetil; 1988 Sep; 129(36):1917-21. PubMed ID: 2902550
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine.
    Rao SS; Cann PA; Holdsworth CD
    Scand J Gastroenterol; 1987 Apr; 22(3):332-6. PubMed ID: 2884724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
    Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
    Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulphasalazine-induced reversible male infertility.
    Delaere KP; Strijbos WE; Meuleman EJ
    Acta Urol Belg; 1989; 57(1):29-33. PubMed ID: 2566274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
    Rubinstein BE
    Ugeskr Laeger; 1982 Feb; 144(5):304-6. PubMed ID: 6122297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.